Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in...
Transcript of Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in...
![Page 1: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/1.jpg)
Robert E. Schoen, MD, MPH Professor of Medicine & Epidemiology
Chief, Division of Gastroenterology University of Pittsburgh, Pittsburgh, PA
Advances in
Colorectal Cancer Screening
![Page 2: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/2.jpg)
Focus
1) Screening at younger age: 45 – 49? 2) Blood based screening for cancer 3) Surveillance colonoscopy
![Page 3: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/3.jpg)
U.S. CRC Annual % Change
Mortality ’84 - ’02 ’01 – ‘10
Male -1.9 -3.0
Female -1.8 -3.0
Incidence
’95 - ’98 ’98 - ’04 ’01 – ‘10
1.1 -2.8 -3.8
1.9 -2.4 -3.2
Espey, Cancer 2007;Oct 15 Siegel R. CA Cancer J Clin 2014:64:104
![Page 4: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/4.jpg)
Siegel R. CA Cancer J Clin 2014:64:104
U.S. CRC Incidence and Mortality Trends
![Page 5: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/5.jpg)
A qualified recommendation indicates there is clear evidence of benefit but less certainty about the balance of benefits and harms
The ACS recommends that adults aged 45 yr and older with an average risk of CRC undergo regular screening
The recommendation to begin screening at age 45y is a qualified recommendation
American Cancer Society: Changes Age to Initiate Screening
Wolf. CA Cancer J Clin 2018;68:250-281
![Page 6: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/6.jpg)
Should we begin CRC screening at age 45?
NO
![Page 7: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/7.jpg)
U.S. CRC Incidence by Age
Siegel R. CA Cancer J Clin 2014:64:104
![Page 8: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/8.jpg)
CRC Incidence 45-49 Relative to Older Age Groups
Rate at 45-49 (33/100K):
Age Proportional Rate
50-54 55-59 60-65 65-69 70-74 75-79
0.53 0.47 0.37 0.28 0.23 0.18
45-49 CRC Rate is a Fraction
of Older Age Groups
In 2015:
![Page 9: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/9.jpg)
Rising Incidence CRC in Young Adults
• Assumed 1.59 fold increase in incidence ratio:
Peterse, Cancer 2018
40 y.o. in 2015 40 y.o. in 1975
![Page 10: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/10.jpg)
Uncertainties • Is the incidence in 1975 accurately
estimated? - How much of increase in incidence is true and how much is due to ↑’d colonoscopy use?
• Does young onset CRC follow similar natural history/adenoma progression?
• Will screening be as effective in mitigating CRC in younger ages as it is in older folks?
![Page 11: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/11.jpg)
• Modeling is not reality – it’s an approximation
• Modeling is dependent on assumptions which are estimates
• Moreover, the translation of modeling results into public policy is complex with no set guideline or formula
Modeling
![Page 12: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/12.jpg)
U.S.P.S.T.F. on Screening for CRC
FSG q5 years: Modeling suggests FSG provides less
benefit than when combined with FIT or with other strategies
JAMA. 2016;315(23):2564-2575!
![Page 13: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/13.jpg)
• Model rejecting the reality of 4 RCTs with >450K subjects
• Models are based on 100% compliance!
• USPSTF rejected model conclusions – endorsed FSG screening
FSG q5yr vs. FSG q10y + FIT q1y
![Page 14: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/14.jpg)
. 62.4%
NHIS: % of U.S. Adults Up to Date with Screening: 2000-2015
We still have a lot of work to do
![Page 15: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/15.jpg)
Disparity in Screening for CRC
Ethnicity Hispanic 49.8 Non-Hispanic 64.2
Education < HS 46.1 College Grad 70.6
Annual Income < 15k 47.6 > 75k 72.9
Insurance Yes 65.7 No 35.6
MMWR 2010;59:808
![Page 16: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/16.jpg)
Randomized Trial of CS vs FIT vs Usual Care
CS FIT Usual
Parkland Hospital in Dallas – N = 5,999
38.4
41
51.7
1o Outcome 2 FIT’s Any
28.0
41.5
65
10.7
10.7
39
Of 162 FIT+, 83 (51%) did not undergo CS
Singal, JAMA 2017: 318:506
% Compliant
![Page 17: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/17.jpg)
We should focus our efforts on groups more likely to benefit; adding lower risk folks will dilute the number who benefit
overall
![Page 18: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/18.jpg)
• New guidelines are encouraging screening a lower risk group when we already don’t sufficiently screen higher risk group
• I suspect we will see a lot of healthy 45 year olds getting tested – Kale- eating marathoners
• Over 21 million people between 45-49 – crowd out capacity for getting those who need it tested
Impression
![Page 19: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/19.jpg)
Intended
CRCpreven,onin45-49yearagegroup
CRCpreven,oninhigh-riskminoritygroups
Increaseinscreeningratesin≥50yearagegroup
Unintended
Diversionofresourcestolower-riskpopula,on
Increaseinscreeningdispari,es
Substan,alcost
Lostopportunitytostudyscreeningeffec,venessinyoungeradults
Actualbenefitsmayfallshortofpredic,ons
Liang. Gastroenterology 2018
Consequences
![Page 20: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/20.jpg)
FIT test + Stool DNA
![Page 21: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/21.jpg)
• Sales up 168% to 266M 2017 • Project 420M in 2018 • Revenue/Cologuard test: $500.00 • Screened 571K in 2017 • Planning to position themselves in
market place for 45-50
![Page 22: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/22.jpg)
Blood-based Screening for Cancer
Bert Vogelstein
Ken Kinzler
Nick Papadopoulos
![Page 23: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/23.jpg)
![Page 24: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/24.jpg)
ctDNA: Circulating Tumor DNA • As cancer cells turn over, release DNA into
adjacent media • Blood, stool, urine, pancreatic juice, cysts,
cervical mucous, CSF, saliva, bronchial, etc. • Detecting Mutant DNA – somatic mutations
within driver genes that are responsible for clonal growth
• Exquisite specificity – normal cells do not clonally expand, rarely harbor these somatic mutations, and not in this concentration
![Page 25: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/25.jpg)
Challenges
• Biological: 1) Are there detectable amounts of
DNA from neoplastic cells present in the biological fluid?
2) Somatic mutations vary - panel 3) Mutations not specific to one cancer
![Page 26: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/26.jpg)
Challenges
• Sensitivity – can be <1 mutant molecule/ml of plasma: requires large volume plasma for testing
• Application: How to identify tissue of origin – same gene mutations drive multiple tumors
![Page 27: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/27.jpg)
Digital Genomics: Safe-SeqS
Method for detection and
quantification of rare mutations
Safe Sequencing System
Kinde I et al. PNAS 108:9530-9535, 2011
![Page 28: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/28.jpg)
Kinde I et al. PNAS 2011;108:9530-9535
*
*
Sequencing or Replication Error
Amplification to Distinguish Replication Error vs. Mutation
vs. Legitimate Mutation
![Page 29: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/29.jpg)
ctDNA in Colorectal Cancer: Resectable vs. Advanced Cancer
Be$egowdaetal.SciTranslMed.2014Feb19;6(224):224ra24.
Colorectal: 73% (stage I-III)
![Page 30: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/30.jpg)
¡ 1,005 Cancer Patients § 209 Breast § 288 Colorectal § 45 Esophageal § 44 Liver § 104 Lung § 54 Ovarian § 93 Pancreatic § 68 Stomach
¡ 812 Healthy Controls
¡ No Distant Metastases § 20% Stage I § 49% Stage II § 31% Stage III
¡ Median Age 64 years
CohenJ,etal.Science2018
![Page 31: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/31.jpg)
CancerSEEK Test
61 amplicons, average 33 bp length, in 16 genes, 2001 genomic positions
![Page 32: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/32.jpg)
Protein Markers
• ctDNA not sensitive enough proteins • Use high cut offs to insure maximum
specificity • 8 proteins useful
![Page 33: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/33.jpg)
Protein Markers Used in CancerSEEK
• CA-125 • CA19-9 • CEA • HGF • Myeloperoxidase • OPN • Prolactin • TIMP-1
![Page 34: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/34.jpg)
CancerSEEK:Detec,on• N= 1005 (288 CRC: Stage I-III)
• Median Age 64 years
Cohen,etal.Science2018
![Page 35: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/35.jpg)
Ovary Liver Colon Lung BreastPancreasStomach Esoph
• 70% Median Sensitivity (p < 10-96 one-sided binominal) • >99% Specificity (7 of 812 Healthy Controls) • Range (33% to 98%)
69% to 98%
![Page 36: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/36.jpg)
78% 73%
43%
Cohen,etal.Science2018
![Page 37: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/37.jpg)
Tissue Confirmation
• Mutation in plasma identical to mutation in tumor in 138/153 (90%)
• Concordance between plasma and tumor: present in all tumor types – ranging from 100% in ovarian/pancreas to 82% in stomach
N=153
![Page 38: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/38.jpg)
YES
![Page 39: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/39.jpg)
Cancer Site of Origin?
• Machine learning in 626 patients with positive test
• Uses ctDNA mutation, protein biomarker, gender
![Page 40: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/40.jpg)
Top Prediction was correct in a median of 63% of the cases.
(p < 10-47 one-sided binomial test)
Top 2 Prediction identified the site in a median of 83% of the cases.
(p < 10-77 one-sided binomial test)
![Page 41: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/41.jpg)
¡ Mostpatientsinthisstudywerediagnosedonthebasisofsymptomaticdisease.
¡ Controlsforthisstudywerelimitedtohealthyindividuals.
¡ Ten-foldcross-validationwasusedfordevelopingthealgorithms-notseparatevalidationcohort.
¡ TheproportionofcancerstypeswasnotrepresentativeofthoseintheUnitedStates.
¡ EstablishingtheclinicalutilityofCancerSEEKwillrequireprospectivestudies.
![Page 42: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/42.jpg)
Cancer Screening: Summary
• CRC screening proven effective • Evidence/Support for screening 45 –
49 yr olds is tepid • Blood based screening on horizon
![Page 43: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/43.jpg)
Surveillance Colonoscopy
25% of Colonoscopy
is for Surveillance
![Page 44: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/44.jpg)
Anticipate Significant Increase in Future Demand For Surveillance Colonoscopy
• Increased Screening • Increasing Adenoma Detection Increased Surveillance
CRC screening begets polyps
![Page 45: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/45.jpg)
Current Surveillance Recommendations
![Page 46: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/46.jpg)
Click B, Pinsky PF, Hickey T, Doroudi M, Schoen RE
University of Pittsburgh, NCI, IMS
Click. JAMA 2018:319:2021
JAMA | Original Investigation
Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence Benjamin Click, MD; Paul F. Pinsky, PhD; Tom Hickey, BS; Maryam Doroudi, PhD, MPH; Robert E. Schoen, MD, MPH
![Page 47: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/47.jpg)
To examine the relationship between adenoma findings on colonoscopy and long-term, subsequent CRC incidence
Aim
![Page 48: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/48.jpg)
AA N=2,882
NAA N=5,068
NA N=7,985
CS N=15,935
≥ 1 cm N= 2,178
< 1 cm N= 704
≥ 3 N= 572
1-2 N= 4,496
![Page 49: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/49.jpg)
Long-term CRC Incidence
![Page 50: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/50.jpg)
Long-term CRC Incidence
Although no cancer difference in NAA vs NA More Surveillance in NAA group
![Page 51: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/51.jpg)
Summary: Surveillance Colonoscopy
• General and widespread recognition that surveillance colonoscopy requires further study
• Surveillance is costly and of uncertain benefit
• A randomized design will provide the strongest, most definitive answers
![Page 52: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/52.jpg)
![Page 53: Advances in Colorectal Cancer Screening › wp-content › uploads › 2018 › ... · Advances in Colorectal Cancer Screening . Focus 1) Screening at younger age: 45 – 49? 2) Blood](https://reader036.fdocuments.us/reader036/viewer/2022070816/5f0f575f7e708231d443ae27/html5/thumbnails/53.jpg)
USPSTF Modeling: Why not FSG q5y?
Model COLs LYG
CRC Deaths Averted
ER <39
Outcome per 1000 40 year olds:
LYG >247 Rec’d
1820
2289
221
256
20
23
Yes
Yes
No
Yes
No
Yes
Knudsen, JAMA 2016; 315 USPSTF, JAMA 2016:315
Sig q5
Sig q10 + FIT q1
FIT q1
Col q10
244
270
22
24
1757
4049